RecruitingNCT07034157

A Real-World Study on Ultrasound-Based Screening and Integrated Therapeutic Strategies for Patients With Concomitant Coronary and Cervicocephalic Artery Stenosis


Sponsor

Beijing Anzhen Hospital

Enrollment

1,000 participants

Start Date

Jun 9, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This prospective observational cohort study aims to investigate the prevalence and clinical significance of head and neck arterial stenosis in patients with coronary artery disease (CAD) undergoing or scheduled for percutaneous coronary intervention (PCI). Using Doppler ultrasound as the primary screening tool, the study will assess the degree of stenosis and evaluate the impact of different combined treatment strategies on patient outcomes. The research will provide real-world evidence to optimize integrated care approaches for patients with comorbid cardiovascular and cerebrovascular diseases.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Cerebrovascular Intervention (CAS ), No Intervention / Observation, and others for people with carotid artery stenosis, cerebrovascular disorders, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPercutaneous Coronary Intervention

Coronary stenting performed as part of routine care for patients with coronary artery stenosis.

PROCEDURECerebrovascular Intervention (CAS )

Patients with intervention-indicated head and neck artery stenosis will receive carotid artery stenting based on clinical evaluation.

OTHERNo Intervention / Observation

Clinical observation or standard follow-up in patients without significant disease


Locations(1)

Beijing Anzhen Hospital

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07034157


Related Trials